Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rationalization of the Systemic Treatment of Age-related Macular Degeneration With Rheohemapheresis (RHF)

NCT01943396 is registered in ClinicalTrials.gov with University Hospital Hradec Kralove as lead sponsor.

NCT NCT01943396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01943396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rationalization of the Systemic Treatment of Age-related Macular Degeneration With Rheohemapheresis (RHF)
Lead sponsor
University Hospital Hradec Kralove
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2013
Completion date
September 30, 2016
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration